Literature DB >> 25483529

A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.

Angela Bechini1, Cristina Taddei, Alessandro Barchielli, Miriam Levi, Emilia Tiscione, Maria Grazia Santini, Fabrizio Niccolini, Maria Teresa Mechi, Donatella Panatto, Daniela Amicizia, Chiara Azzari, Paolo Bonanni, Sara Boccalini.   

Abstract

Invasive pneumococcal diseases (IPD) and community acquired pneumonia (CAP) represent two of the major causes of out-patient visits, hospital admissions and deaths in the elderly. In Tuscany (Italy), in the Local Health Unit of Florence, a project aimed at implementing an active surveillance of pneumococcal diseases in the hospitalized elderly population started in 2013. The aim of this study is to show the results of the retrospective analysis (2010-2012) on hospital discharge records (HDRs) related to diseases potentially due to S. pneumoniae, using a selection of ICD9-CM codes. All ordinary hospitalizations (primary and secondary diagnoses) of the elderly population were included (11 245 HDRs). Among a population of about 200 000 inhabitants ≥65 y, the hospitalization rate (HR) increased with increasing age and was higher in males in all age groups. Almost all hospitalizations (95%) were due to CAP, only 5% were invasive diseases. Only few cases of CAP were specified as related to S. pneumoniae, the percentage was higher in case of meningitis (100%) or septicemia (22%). In-hospital deaths over the three-year period were 1703 (case fatality rate: 15%). The risk of dying, being hospitalized for a disease potentially attributable to pneumococcus (as primary diagnosis) increased significantly with age (P < 0.001), the odds ratio (OR) per increasing age year was 1.06 (95% CI 1.05-1.07) and was higher in patients with co-existing medical conditions with respect to patients without comorbidities. Currently, an active surveillance system on S. pneumoniae diseases with the inclusion of bio-molecular tests (RT-PCR), is a key step to assess the effectiveness of the PCV13 vaccine (13-valent pneumococcal conjugate vaccine) in the elderly population after implementation of vaccination policies. The results of this study will provide the comparator baseline data for the evaluation of a possible immunization programme involving one or more cohorts of the elderly in Tuscany.

Entities:  

Keywords:  Italy; Pneumococcal conjugate vaccine; Streptococcus pneumoniae; Tuscany; elderly; hospitalizations; immunization policies

Mesh:

Year:  2014        PMID: 25483529      PMCID: PMC4514361          DOI: 10.4161/hv.34418

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  28 in total

1.  Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.

Authors:  Mark van der Linden; Susanne Weiß; Gerhard Falkenhorst; Annette Siedler; Matthias Imöhl; Rüdiger von Kries
Journal:  Vaccine       Date:  2012-07-04       Impact factor: 3.641

2.  National hospitalization trends for pediatric pneumonia and associated complications.

Authors:  Grace E Lee; Scott A Lorch; Seth Sheffler-Collins; Matthew P Kronman; Samir S Shah
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

3.  23-valent pneumococcal polysaccharide vaccine. WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2008-10-17

4.  Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.

Authors:  Giovanni Viegi; Riccardo Pistelli; Mario Cazzola; Franco Falcone; Isa Cerveri; Andrea Rossi; Giuseppe Ugo Di Maria
Journal:  Respir Med       Date:  2005-07-20       Impact factor: 3.415

Review 5.  Immune dysfunction and infections in patients with cirrhosis.

Authors:  Alexander R Bonnel; Chalermrat Bunchorntavakul; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

6.  Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013.

Authors:  Domenico Martinelli; Biagio Pedalino; Maria Giovanna Cappelli; Giovanni Caputi; Anna Sallustio; Francesca Fortunato; Silvio Tafuri; Vanessa Cozza; Cinzia Germinario; Maria Chironna; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

Review 7.  Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13 - valent polysaccharide conjugate vaccine.

Authors:  C Alicino; I Barberis; A Orsi; P Durando
Journal:  Minerva Med       Date:  2014-02       Impact factor: 4.806

8.  The burden of hospitalised pneumonia in Lazio, Italy, 1997-1999.

Authors:  P Giorgi Rossi; N Agabiti; A Faustini; C Ancona; V Tancioni; F Forastiere; C A Perucci
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

Review 9.  Pneumonia in the elderly.

Authors:  Mark Loeb
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

10.  Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.

Authors:  Fangjun Zhou; Moe H Kyaw; Abigail Shefer; Carla A Winston; J Pekka Nuorti
Journal:  Arch Pediatr Adolesc Med       Date:  2007-12
View more
  3 in total

1.  Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?

Authors:  Sara Boccalini; Ornella Varone; Martina Chellini; Luca Pieri; Antonino Sala; Cesare Berardi; Paolo Bonanni; Angela Bechini
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

2.  Estimation of the incidence of hospitalization for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older.

Authors:  Trude Marie Lyngstad; Anja Bråthen Kristoffersen; Brita Askeland Winje; Anneke Steens
Journal:  Epidemiol Infect       Date:  2022-04-04       Impact factor: 4.434

Review 3.  Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.

Authors:  Andrea Orsi; Filippo Ansaldi; Cecilia Trucchi; Roberto Rosselli; Giancarlo Icardi
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.